Executive Director Therapeutic Area Strategy Oncology and Hematology

**Salary Range:** CHF169,400.00 - CHF314,600.00   **Band** Level 7   **Job Description Summary** Location: Cambridge MA, East Hanover NJ, US or Basel Switzerland. This role will follow a hybrid working model. If based in US, please apply to REQ-10076159 LI-#hybrid The Novartis Strategy & Growth, Therapeutic Area Strategy team for Oncology & Hematology is seeking a new Executive Director, Therapeutic Area Strategy who will support the creation and update of a holistic TA strategy; provide early-phase commercial insights to project teams; guide TA-specific internal pipeline development and external licensing / acquisitions opportunities; and support integrated enterprise alignment across Biomedical Research (BR), Development, Strategy & Growth (S&G), and the Commercial US and International units.   **Job Description** **Key Responsibilities:** * Brings external benchmarking, analysis and insights, and judgement to support the TA Strategy Head in developing a holistic Novartis TA strategy that achieves sustainable growth in short, mid and long-term. * Brings both understanding of the pharmaceutical industry and the core Therapeutic Areas (TA) and Disease area of Oncology & Hematology to derive insightful and differentiating competitive advantages over our peers. * Provides key commercial insights to the R&D project teams, particularly for early phase programs. To do this effectively, in-market experience in the US is critical. * Analyses reports and publications to extract key messages, including building product forecasts. * Supports development and delivery of TA-specific strategic external insights to support identification of growth opportunities, emerging competitive challenges and support creation of a third-party view around key strategic levers, and commissions targeted primary research. **Essential Requirements:** * Bachelor's degree required. Advanced degree (PhD, MD or other advanced University degree) and / or equivalent experience in life science/healthcare; MBA or consulting or equivalent experience highly preferred. * In-depth TA knowledge (or track record to acquire required TA expertise effectively and rapidly) in Oncology and/or Hematology. * Highly agile having the capacity to support a number of strategic DAs within a TA and multiple programs internal and external * Substantial experience evaluating new product opportunities (through M&A, BD&L and internal re-search programs). * 7-10 years of Industry pharma and/or medical devices Experience in Research & Development and/or commercial functions with experience conducting, commissioning, analyzing primary research * Experience of strategy development and asset shaping early in lifecycle (any functional perspective) * Recent (post 2015) local US in-market experience; local US experience includes working within the US market with the local US customers, US health care systems / systems **Commitment to Diversity and Inclusion:** Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve. **Accessibility and Accommodation:** Novartis is committed to working with and providing reasonable accommodation to all individuals. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the recruitment process, or in order to receive more detailed information about the essential functions of a position, please send an e-mail to [diversity.inclusion\[email protected]](mailto:[email protected]) and let us know the nature of your request and your contact information. Please include the job requisition number in your message.   **Skills Desired** Agile (Programming Methodology) (Inactive), Building Constructions, Business Development, Business Strategies, Communication, Curious Mindset, Data Analytics, Decision Making, Digital Oscilloscope, Finance, Go-to-Market Strategies, Influencing Skills, Leadership, Operations (Inactive), Pipeline (Software) (Inactive), Prioritization, Strategic Alliances, Strategic Planning